Contemporary Treatment and Survival Outcomes in Mantle Cell Lymphoma: A National Real-World Analysis From REALYSA, a LYSA Cohort. [PDF]
Cheminant M +33 more
europepmc +1 more source
Humoral influence on cytotoxicity in myeloid leukemia therapies. [PDF]
Pratz KW.
europepmc +1 more source
More precise risk stratification for de novo acute myeloid leukemia with double-mutation CEBPA. [PDF]
Liu JJ, Yang HP, Hu M.
europepmc +1 more source
Distinguishing chronic myeloid leukemia in megakaryocytic blast crisis from <i>de novo</i> Ph+ acute megakaryoblastic leukemia: a case report and systematic review. [PDF]
Liu Q, Yu P, Li X, Lan H, Liu Z.
europepmc +1 more source
Higher Cumulative Cytarabine Consolidation Improves Survival in Older Adults with Acute Myeloid Leukemia. [PDF]
Mudd TW +10 more
europepmc +1 more source
Anthracycline-Free FLA-VEN with or Without Midostaurin in Newly Diagnosed Intermediate- and Adverse-Risk AML: A Single-Center Retrospective Study. [PDF]
Namdaroglu S +8 more
europepmc +1 more source
Outcomes of adolescents and young adults with AML treated on pediatric vs adult protocols. [PDF]
Krayem B +14 more
europepmc +1 more source
Myelodysplastic Syndromes-Transformed Acute Myeloid Leukemia With Concurrent DEK::CAN Fusion Gene Positivity and WT1 Overexpression: A Case Report and Literature Review. [PDF]
Mao W +5 more
europepmc +1 more source
Efficacy and Safety of CLAG-Based Sequential Conditioning Followed by Allogeneic Hematopoietic Stem Cell Transplantation in Non-Remission Relapsed or Refractory Acute Leukemia. [PDF]
Chen S, Zhang X, Li X, Du X.
europepmc +1 more source
Newly diagnosed acute myeloid leukemia in Fit patients: 2026 treatment algorithms. [PDF]
Gangat N, Ravandi F.
europepmc +1 more source

